S
VOR icon

SignatureFD’s Vor Biopharma VOR Stock Holding History

SignatureFD’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71K Buy
147
+108
+277% +$1.63K ﹤0.01% 3071
2026
Q1 		$696 Buy
+39
New +$550 ﹤0.01% 3268
2022
Q1 		– Sell
-29
Closed -$7K – 3340
2021
Q4 		$7K Buy
29
+21
+263% +$6.05K ﹤0.01% 2301
2021
Q3 		$2K Buy
8
+5
+167% +$1.49K ﹤0.01% 2719
2021
Q2 		$1K Buy
+3
New +$1.48K ﹤0.01% 2855

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

SignatureFD's VOR Position: Q2 2026 in Review

SignatureFD increased its Vor Biopharma (VOR) stake by 277% in Q2 2026, buying an estimated $1.63K and bringing the position to 147 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #3071.

SignatureFD first reported a position in VOR in Q2 2021 and has held it in 5 quarters since. The position peaked at $7K in Q4 2021. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • SignatureFD held 147 shares of Vor Biopharma worth $2.71K as of Q2 2026.
  • SignatureFD bought 108 Vor Biopharma shares in Q2 2026, an estimated $1.63K.
  • Vor Biopharma made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3071 holding.
  • SignatureFD first reported a position in Vor Biopharma in Q2 2021 and has held it in 5 quarters since.
  • SignatureFD's Vor Biopharma position peaked at $7K in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.